Zobrazeno 1 - 10
of 496
pro vyhledávání: '"Guillaume Ploussard"'
Autor:
Daniele d?Agate, Bogdan Buhas, Rawad Abou-Zahr, Razvan-George Rahota, Nhan Kien Nguyen, Christophe Almeras, Jean-Baptiste Beauval, Guillaume Ploussard
Publikováno v:
Telemedicine Reports, Vol 5, Iss 1, Pp 114-122 (2024)
Background: Electronic health can help improve perioperative outcomes and overcome organizational constraints related to human resources and health care-related costs. In this initial report, we assess patient compliance with a digital platform inclu
Externí odkaz:
https://doaj.org/article/52c2a3da828f404fa11879af1f64363e
Autor:
Diego Teyssonneau, Charles Dariane, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau, Gaëlle Fiard, Gaëlle Fromont, Gilles Créhange, Mathieu Gauthé, Alain Ruffion, Raphaële Renard-Penna, Romain Mathieu, Paul Sargos, Morgan Rouprêt, Guillaume Ploussard, Guilhem Roubaud
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Despite several improvements in outcomes, metastatic prostate cancer remains deadly. Alterations in the homologous recombination repair (HRR) pathway are associated with more aggressive disease. Olaparib and rucaparib, two poly-ADP-ribose polymerase
Externí odkaz:
https://doaj.org/article/606b9941033847df92fef1473b6f1a9c
Autor:
Giuseppe Fallara, Daniele Robesti, Daniele Raggi, Francesco Montorsi, Andrea Necchi, Matthew R. Cooperberg, Bernard Malavaud, Guillaume Ploussard, Alberto Martini
Publikováno v:
European Urology Open Science, Vol 52, Iss , Pp 40-43 (2023)
The PROpel trial assessed the combination of olaparib + abiraterone acetate (AA) plus prednisone and androgen deprivation therapy (ADT) versus AA plus prednisone and ADT alone as first-line treatment for metastatic castration-resistant prostate cance
Externí odkaz:
https://doaj.org/article/39ada7f2ca74494fb33cd14f94ba6048
Autor:
Markus von Deimling, Laura S. Mertens, Bas W.G. van Rhijn, Yair Lotan, Philippe E. Spiess, Siamak Daneshmand, Peter C. Black, Maximilian Pallauf, David D'Andrea, Marco Moschini, Francesco Soria, Francesco Del Giudice, Luca Afferi, Ekaterina Laukhtina, Takafumi Yanagisawa, Tatsushi Kawada, Jeremy Y.-C. Teoh, Mohammad Abufaraj, Guillaume Ploussard, Mathieu Roumiguié, Pierre I. Karakiewicz, Marko Babjuk, Paolo Gontero, Evanguelos Xylinas, Michael Rink, Shahrokh F. Shariat, Benjamin Pradere
Publikováno v:
European Urology Open Science, Vol 51, Iss , Pp 39-46 (2023)
Background: There are currently no guideline recommendations regarding the treatment of cisplatin-ineligible, clinically lymph node–positive (cN+) bladder cancer (BCa). Objective: To investigate the oncological efficacy of gemcitabine/carboplatin i
Externí odkaz:
https://doaj.org/article/ca1ab60ba464424d84a6c7187bdbb8f7
Publikováno v:
European Urology Open Science, Vol 59, Iss , Pp 5-6 (2024)
Externí odkaz:
https://doaj.org/article/d28eac4a0907456d84e1899c9fdd9928
Autor:
Alae Touzani, Gaëlle Fiard, Eric Barret, Raphaële Renard-Penna, Ambroise Salin, Benjamin Pradère, François Rozet, Jean-Baptiste Beauval, Bernard Malavaud, Gianluca Giannarini, Pierre Colin, Morgan Rouprêt, Guillaume Ploussard
Publikováno v:
European Urology Open Science, Vol 45, Iss , Pp 76-80 (2022)
PERFECT is a multicentre randomised controlled clinical trial that evaluates the efficiency of fusion magnetic resonance imaging–targeted biopsies in the transperineal (TP) versus transrectal (TR) approach in terms of the detection of significant c
Externí odkaz:
https://doaj.org/article/0cad304b1e4349c0920fae137433e155
Autor:
Amine Saouli, Alain Ruffion, Charles Dariane, Eric Barret, Gaëlle Fiard, Gaelle Fromont Hankard, Gilles Créhange, Guilhem Roubaud, Jean Baptiste Beauval, Laurent Brureau, Raphaëlle Renard-Penna, Mathieu Gauthé, Michael Baboudjian, Guillaume Ploussard, Morgan Rouprêt
Publikováno v:
Cancers, Vol 15, Iss 22, p 5485 (2023)
The aim of this study was to systematically review the current evidence regarding the oncological and functional outcomes of salvage radical prostatectomy (sRP) for recurrent prostate cancer. A systematic review was conducted throughout September 202
Externí odkaz:
https://doaj.org/article/62182f25da8641c1bb60d4d4877cc36d
Autor:
Thomas Bommelaere, Arnauld Villers, Philippe Puech, Guillaume Ploussard, Julien Labreuche, Elodie Drumez, Xavier Leroy, Jonathan Olivier
Publikováno v:
European Urology Open Science, Vol 41, Iss , Pp 24-34 (2022)
Background: The risk of prostate cancer metastatic is correlated with its volume and grade. These parameters are now best estimated preoperatively with magnetic resonance imaging (MRI) and MRI-guided biopsy. Objective: To estimate the risk of metasta
Externí odkaz:
https://doaj.org/article/bf1a3f47b6484ec184ece2b007f4c38c
Autor:
Michael Baboudjian, Pawel Rajwa, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau, Gilles Créhange, Charles Dariane, Gaëlle Fiard, Gaëlle Fromont, Mathieu Gauthé, Romain Mathieu, Raphaële Renard-Penna, Guilhem Roubaud, Alain Ruffion, Paul Sargos, Morgan Rouprêt, Guillaume Ploussard
Publikováno v:
European Urology Open Science, Vol 41, Iss , Pp 35-44 (2022)
Context: Previous reports have shown an association between vasectomy and prostate cancer (PCa). However, there exist significant discrepancies between studies and systematic reviews due to a lack of strong causal association and residual confounding
Externí odkaz:
https://doaj.org/article/b4afc4c00f8d456ab7d294f4992177ed
Autor:
Bogdan Adrian Buhas, Valentin Toma, Nicolae Crisan, Guillaume Ploussard, Teodor Andrei Maghiar, Rareș-Ionuț Știufiuc, Constantin Mihai Lucaciu
Publikováno v:
Biosensors, Vol 13, Iss 8, p 813 (2023)
Renal cell carcinoma (RCC) represents the sixth most frequently diagnosed cancer in men and is asymptomatic, being detected mostly incidentally. The apparition of symptoms correlates with advanced disease, aggressive histology, and poor outcomes. The
Externí odkaz:
https://doaj.org/article/2d1a6b000e444b69bd7b4c010b24d537